[Clinical results observed with tyrosine kinase inhibitors].
Pérol
Maurice
M
Hôpital de la Croix-Rousse, Service de pneumologie, 93, Grande Rue de la Croix-Rousse, 69317 Lyon Cedex 4.
D001984:Bronchial Neoplasms / Q000188:drug therapy* / Q000201:enzymology; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000201:enzymology; D000069347:Erlotinib Hydrochloride; D006801:Humans; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011799:Quinazolines / Q000627:therapeutic use*; D016896:Treatment Outcome
D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; D011505:Protein-Tyrosine Kinases